[Evaluation of minocycline (7-dimethylamino-6-demethyl-6-deoxytetracycline) in the dermatological field].
D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000818:Animals; D002675:Child, Preschool; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005667:Furunculosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013492:Suppuration / Q000188:drug therapy; D013752:Tetracycline / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*
D013752:Tetracycline